Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped reduce levels of brain atrophy and neuroinflammation.

A new USC-led study suggests that assessing blood vessel health should be included in dementia diagnostics. A new USC-led ...

Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...

Many of our scientists are focussed on developing treatments that can slow down or stop the diseases that cause dementia. This work is vital, as currently there are no drugs available on the NHS that ...

And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...